A decapeptide fragment of kisspeptin, a key upstream regulator of reproductive hormones, studied in fertility and reproductive-neuroendocrine research.
Mechanism under study
Kisspeptin-10 stimulates hypothalamic neurons via the KISS1R (GPR54) receptor to trigger GnRH release, which in turn drives pituitary LH and FSH secretion and downstream sex-hormone production.
Research-reported dosing
Investigational; administered in research as boluses or infusions to probe reproductive-hormone signaling. No established therapeutic dosing.
Dosing figures describe how this compound appears in the research literature and research-community references. They are not a recommendation for human use.
Kisspeptin-10 FAQ
What is Kisspeptin-10?
A decapeptide fragment of kisspeptin, a key upstream regulator of reproductive hormones, studied in fertility and reproductive-neuroendocrine research.
What is the half-life of Kisspeptin-10?
Very short — reported in minutes; longer-acting forms such as kisspeptin-54 are also studied.
What is the research-reported dosing for Kisspeptin-10?
Investigational; administered in research as boluses or infusions to probe reproductive-hormone signaling. No established therapeutic dosing.
How is Kisspeptin-10 reconstituted?
5 mg vial + 2 mL bacteriostatic water = 2500 mcg/mL.
Is Kisspeptin-10 FDA-approved?
No — Kisspeptin-10 is investigational and not FDA-approved. It is sold for laboratory research use only.
References
Related peptides
Gonadorelin
Synthetic GnRH decapeptide
A synthetic form of gonadotropin-releasing hormone (GnRH). It has established diagnostic and fertility uses and is also used off-label to support endogenous hormone production.
PT-141
Melanocortin receptor agonist
A melanocortin-receptor agonist, FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Studied for arousal via central nervous-system pathways rather than the vascular route.
Melanotan II
Melanocortin receptor agonist
A synthetic melanocortin agonist studied for skin pigmentation (tanning) and, secondarily, arousal. It is not approved, and research notes meaningful safety considerations.